Company Overview ImmuPharma (IMM) is a specialty biopharmaceutical company focused on developing novel medications for serious, chronic autoimmune and inflammatory diseases. Founded in 1999 and headquartered in London, UK, with research operations in France, the company operates with a business model centered on developing innovative therapeutics through to late-stage clinical trials, then partnering with larger […]
How Artificial Intelligence is Transforming Drug Discovery, Development, and Personalization Introduction: The AI Pharma Boom Drug discovery has traditionally been expensive, slow, and prone to failure. Developing a single drug can take over a decade and cost billions. However, AI is revolutionizing this process, dramatically accelerating drug research, reducing costs, and improving efficiency. Pharmaceutical companies, […]
Introduction The convergence of artificial intelligence (AI) and quantum computing holds the potential to revolutionize healthcare on an unprecedented scale. While AI is already transforming diagnostics, treatment planning, and operational efficiency, quantum computing promises to tackle challenges that are currently beyond the capabilities of classical computing. These advancements can accelerate drug discovery, solve intricate biological […]
